Seroatlas · Human Serome Atlas

FAAH2

Fatty-acid amide hydrolase 2

Also known as: AMDD, FAAH-2, FAAH2_HUMAN, FLJ31204, RP11-479E16.1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6GMR7
Gene
FAAH2
Ensembl
ENSG00000165591
Chromosome
X
Canonical length
532 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes a fatty acid amide hydrolase that shares a conserved protein motif with the amidase signature family of enzymes. The encoded enzyme is able to catalyze the hydrolysis of a broad range of bioactive lipids, including those from the three main classes of fatty acid amides; N-acylethanolamines, fatty acid primary amides and N-acyl amino acids. This enzyme has a preference for monounsaturated acyl chains as a substrate. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]

Canonical amino-acid sequenceUniProt

532 residues, UniProt reviewed canonical sequence.

>Q6GMR7|FAAH2
     1  MAPSFTARIQ LFLLRALGFL IGLVGRAALV LGGPKFASKT PRPVTEPLLL LSGMQLAKLI
    61  RQRKVKCIDV VQAYINRIKD VNPMINGIVK YRFEEAMKEA HAVDQKLAEK QEDEATLENK
   121  WPFLGVPLTV KEAFQLQGMP NSSGLMNRRD AIAKTDATVV ALLKGAGAIP LGITNCSELC
   181  MWYESSNKIY GRSNNPYDLQ HIVGGSSGGE GCTLAAACSV IGVGSDIGGS IRMPAFFNGI
   241  FGHKPSPGVV PNKGQFPLAV GAQELFLCTG PMCRYAEDLA PMLKVMAGPG IKRLKLDTKV
   301  HLKDLKFYWM EHDGGSFLMS KVDQDLIMTQ KKVVVHLETI LGASVQHVKL KKMKYSFQLW
   361  IAMMSAKGHD GKEPVKFVDL LGDHGKHVSP LWELIKWCLG LSVYTIPSIG LALLEEKLRY
   421  SNEKYQKFKA VEESLRKELV DMLGDDGVFL YPSHPTVAPK HHVPLTRPFN FAYTGVFSAL
   481  GLPVTQCPLG LNAKGLPLGI QVVAGPFNDH LTLAVAQYLE KTFGGWVCPG KF

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FAAH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.21
Highest tissue expression
14 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 14 nTPM
  • parathyroid gland: 13 nTPM
  • liver: 9.8 nTPM
  • skin: 9.2 nTPM
  • prostate: 6.9 nTPM
  • thymus: 6.8 nTPM

Single-cell type

  • pancreatic acinar cells: 458 nCPM
  • somatotrophs: 413 nCPM
  • thyrotrophs: 364 nCPM
  • lactotrophs: 363 nCPM
  • plasma cells: 303 nCPM
  • prostatic glandular cells: 294 nCPM

Immune cell

  • T-reg: 17 nTPM
  • memory CD4 T-cell: 8 nTPM
  • naive CD4 T-cell: 7.8 nTPM
  • MAIT T-cell: 5 nTPM
  • memory CD8 T-cell: 3.4 nTPM
  • memory B-cell: 1.8 nTPM

Brain region

  • cerebellum: 8.1 nTPM
  • hypothalamus: 6.8 nTPM
  • midbrain: 4 nTPM
  • medulla oblongata: 3.7 nTPM
  • pons: 3.7 nTPM
  • basal ganglia: 3.6 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FAAH2.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 222 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.94
gnomAD pLI
0
gnomAD missense Z
-3.63
DepMap mean gene effect
0.11
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FAAH2 as an antibody target. Whether an autoantibody or antibody against FAAH2 could matter depends on whether native FAAH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FAAH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label FAAH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FAAH2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...